FORMULATION AND EVALUATION OF ION-SENSITIVE IN-SITU NASAL GEL OF ZOLMITRIPTAN
Keywords:
In situ gelling, Nasal delivery, Migraine, Polymers, Sustained release, Higher bioavailability etcAbstract
In situ gel system is novel drug delivery system in which there is transition of sol to gel on external stimuli like change in pH, temperature or change in ion concentration (sol-gel transition). In the present study various formulations were prepared by using gellan gum as gelling agent and HPMC K100 as controlled or sustained release polymer. All the formulations were evaluated for various parameters like pH, viscosity, drug content, gel strength, mucoadhesive strength and drug release. At minimum concentration of polymer lose their integrity and at maximum concentration stiff gel were formed. At optimized concentration of gelling agent and HPMC K100 showed in situ gelling with all parameter in range. In Vitro release data revealed that the optimized formulation showed controlled and sustained drug release pattern. The optimized formulation also obeyed korsmer Peppas model equation and which showed the release exponent n value 0.765. Thus the ex vivo higher bioavailability can be expected from the optimized formulation.
Â
Downloads
References
K Jadhav, M Gambhire. Nasal drug delivery system-factors affecting and applications. Curr Drug Ther 2007;2:27-38.
Akhtar. Enhanced bioavailability of drugs via intranasal drug delivery system. IRJP 2012;7:68-74.
S Badgujar, M Sontakke. Formulation and evaluation of Sumatriptan succinate nasal in-situ gel using Fulvic acid as novel permeation enhancer. IJPRD 2010;2:8.
Merkus, Schipper. Absorption enhancers in nasal drug delivery: efficacy and safety. J Controlled Release 1993;24:201-8.
J Coos Verhoe, Nicolaas GM Schipper, Stefan G Romeijn. The potential of cyclodextrins as absorption enhancers in nasal delivery of peptide drugs. J Controlled Release 1994;29:35l-60.
S Horvat, A Feher. Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue. Eur J Pharm Biopharm 2009;72:252–9.
K Ketousetuo. Development of oxytocin nasal gel using natural mucoadhesive agent obtained from the fruits of Dellinia indica. L Sci Asia 2007;33:57-60.
L Illum, N Farraj, H Critchley, SS Davis. Nasal administration of Gentamicin using a novel microsphere delivery system. Int J Pharm 1988;46:261-5.
U Bertram, R Bodmeier. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci 2006;27:62–71.
E Marttin, G Nicolaas. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Delivery Rev 1998;29:13–38.
Nasal spray and inhalation solution, suspension, and spray drug products —chemistry, manufacturing, and controls documentation, US Department of health and human services food and drug administration. CDER; 2002.
N Nandgude, R Thube. Formulation and evaluation of pH induced in-situ nasal gel of salbutamol sulphate. Int J Pharm Sci Nanotechnol 2008;1:177-82.
R Shah, Mehta M. Design and evaluation of pH dependant mucoadhesive in situ gel of Sodium cromoglycate for nasal delivery. IJAPR 2011;2:64-77.
P Edman. Characterization of degradable starch microspheres, delivery system for drugs, as a nasal. Int J Pharm 1990;62:187-92.
E Gavini, B Hegge, G Rassu, V Sanna, C Testa. Nasal administration of Carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm 2006;307:9–15.
M Alfadhela, U Puapermpoonsiria, SJ Ford, FJ McInnesa. Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus: in vitro evaluation. Int J Pharm 2011;416:280–7.
Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. Eur J Pharm Sci 2006;2(7):62–71.
H Nazar, DG Fatouros, SM van der Merwe. Thermosensitive hydrogels for nasal drug delivery: the formulation and characterization of systems based on N-trimethyl chitosan chloride. Eur J Pharm Biopharm 2011;77:225–32.
S Basu, A Bandyopadhyay kumar. Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with ficus carica mucilage. Am Assoc Pharm Sci 2010;11:1223-31.
L Pereswetoff-Morath. Microspheres as nasal drug delivery systems. Adv Drug Delivery Rev 1998;29:185–94.
Mi Lan Kang a, Chong Su Cho. Application of chitosan microspheres for nasal delivery of vaccines. Biotechnol Adv 2009;27:857–65.
A Yenet, Nisha M Joseph. Newer advancement in nasal drug delivery system. IJPSR 2010;1:10.
S Basu, AK Bandyopadhyay. Nasal drug delivery: an overview. Int J Pharm Sci Tech. 2010;4(1):1-20.
HS Mahajan, VK Tyagi, RR Patil, SB Dusunge. Thiolated xyloglucan: synthesis, characterization and evaluation as mucoadhesive in situ gelling agent. Carbohydr Polym 2013;91:618–25.
E Bjiirk, S Bjurstriim, P Edman. Morphologic examination of rabbit nasal mucosa after nasal administration of degradable starch microspheres. Int J Pharm 1991;75(1):73-800.
AP Kulkarnia. Evaluation of polaxomer-based in situ gelling system of articaine as a drug delivery system for anesthetizing periodontal pockets-an in vitro study. Indian J Dent 2012;3:201-8.
H Mahajan, B Tatiya, P Nerkar. Ondansetron loaded pectin based microspheres for nasal administration: in vitro and in vivo studies. Powder Technol 2012;221:168–76.
G Fundueanua, M Constantinb, A Dalpiaza. Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foys) in allergic rhinitis treatment. Biomater 2004;25(1):159–70.
C Callens, E Adriaens, K Dierckens, JP Remon. Toxicological evaluation of a bioadhesive nasal powder containing a starch and Carbopol 974 P on rabbit nasal mucosa and slug mucosa. J Controlled Release 2001;76:81–91.
M Amidi, G Stefan, R Borchard, H Junginger. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Controlled Release 2006;111:107–16.
F McInnes, P Thapa, AJ Baillie, PG Welling. In vivo evaluation of nicotine lyophilized nasal insert in sheep. Int J Pharm 2005;304:72–82.
DJ Yadav. Formulation and evaluation of thermo sensitive in situ gel of salbutamol sulphate for nasal. Int J Pharm Pharm Sci 2012;4 Suppl:188.
Rozier C Mazuel, J Grove, B Plazonnet. Functionality testing of Gellan gum, a polymeric excipient material for ophthalmic dosage forms. Int J Pharm 1997;153:191–8.
GR Sanderson. Gellan gum. In P. Harries (Ed.) Food gels New York: Elsevier Science; 1990. p. 201–32.
D Schmaljohann. Thermo-and pH-responsive polymers in drug delivery. Adv Drug Delivery Rev 2006;58(15):1655–70.
CP Pujara, Z Shao, MR Duncan, AK Mitra. Effects of formulation variables on nasal epithelial cell integrity: biochemical evaluation. Int J Pharm 1995;114:197-203.
S Pund, G Rasve, G Borade. Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa. Eur J Pharm Sci 2013;48:195–201.
RSR Murthy, RJ Majithiya, PK Ghosh. Thermo reversible mucoadhesive gel for nasal delivery of Sumatriptan. AAPS Pharm Sci Tech 2006;7(3):E1.
HS Mahajan, SG Gattani. In situ gels of metoclopramide hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Delivery 2010;17:19–24.
V Jitendra, K Shinde, S Mali. In-situ mucoadhesive nasal gels of metoclopramide hydrochloride: preformulation and formulation studies. J Pharm Res 2008;1:1.
V Gaikwad. Formulation and evaluation of in-situ gel of metoprolol tartrate for nasal delivery. J Pharm Res 2010;3(4):788-93.
S Khan, J Desai, Shivakumar HG. Formulation and evaluation of in-situ gel of Diltiazem hydrochloride for nasal delivery. Scholar Res Library 2011;3(1):371-81.
D Badgujar, A Manish, S Sontakke. Formulation and evaluation of sumatriptan succinate nasal in situ gel using fulvic acid as novel permeation enhancer. Int J Pharm Res Dev 2010;2(8):7.
Hyun-jong Cho, Prabagar Balakrishnan. Poloxamer/ Cyclodextrin/Chitosan-Based Thermo reversible Gel for Intranasal Delivery of Fexofenadine Hydrochloride. J Pharm sci 2011;100(2):681-91.
NA Peppas, JJ Shalin. A simple equation for the description of solute release III. Coupling ofdiffusion and relaxation. Int J Pharm 1989;57:169–72.